A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis
A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis
Active, not recruiting · NCT06149559 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis | Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Active, not recruiting | Phase 2 / Phase 3 | 2026-09-25 | NCT06149559 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| UCB Biopharma SRL | 30 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mg0006 20339 | Ōbu | Japan | 1 |
| Mg0006 20340 | Fuchu-shi | Japan | 1 |
| Mg0006 20343 | Sagamihara | Japan | 1 |
| Mg0006 40144 | Milan | Italy | 1 |
| Mg0006 40155 | Warsaw | Poland | 1 |
| Mg0006 40290 | Bologna | Italy | 1 |
| Mg0006 40733 | Naples | Italy | 1 |
| Mg0006 40734 | Lodz | Poland | 1 |
| Mg0006 40841 | Yenimahalle | Turkey (Türkiye) | 1 |